REUTERS/Toby Melville Britain's biggest drugmaker GlaxoSmithKline said on Thursday it had filed for European approval of its new once-weekly diabetes drug albiglutide, as tries to gain a foothold in a crowded market.
GlaxoSmithKline files for European approval of diabetes drug albiglutide